From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Optibiotix names the US “strategic and specialist investor” and it has already been selling shares.

By Tom Winnifrith | Wednesday 4 June 2025


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


On Friday 23 May Optibiotix (OPTI) announced a placing with a US “specialist” investor taking £500,000 of shares at 14p. It did not name that investor but the implication was that this was a kosher long term fundamentals based investor. Even yesterday Steve O'Hara was briefing that it was a "strategic investor." Today it has updated its Rule 26 page and the ghastly truth is starting to slip out.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CLAI

CelAI madness begets madness

Monday »

ICON

Iconic Labs, the world has gone mad!

Time left: 01:26:07